High-turnover osteoporosis and diffuse idiopathic skeletal hyperostosis induced by retinoid therapy in a patient with superficial bladder cancer

Br J Urol. 1995 Sep;76(3):400-1. doi: 10.1111/j.1464-410x.1995.tb07725.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Etretinate / adverse effects*
  • Humans
  • Hyperostosis, Diffuse Idiopathic Skeletal / chemically induced*
  • Male
  • Osteoporosis / etiology*
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Etretinate